Biography
Dirk Schnappinger joined the faculty of the Department of Microbiology and Immunology of Weill Cornell Medical College in 2001.
He received his Ph.D. from the Friedrich-Alexander University of Erlangen-Nürnberg, Germany, in 1998 for his work on the repressor protein that controls the expression of tetracycline resistance in Gram negative bacteria. After his graduate work Dr. Schnappinger began to study the human pathogen Mycobacterium tuberculosis, first at UC Berkeley, in the lab of Dr. Lee Riley, and then at Stanford under the guidance of Dr. Gary Schoolnik, where he helped to adapt microarray-based RNA profiling to the analysis of bacterial pathogens.
His current research focuses on the molecular biology and virulence mechanisms of Mycobacterium tuberculosis. Dr. Schnappinger’s research is supported by the National Institutes of Health, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the Global Alliance for TB Drug Development.
During his career Dr. Schnappinger received fellowships from the German Merit Foundation (“Studienstiftung des Deutschen Volkes”), the German Fonds of the Chemical Industry, the German Research Council and the Ellison Medical Foundation.
